Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Description Reviews 0 About Retatrutide 30mg Retatrutide is a novel triple hormone receptor agonist that simultaneously activates receptors for glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon
Monthly: From $179.00 3-Month Supply: From $399 Insurance accepted or pay out-of-pocket with flexible self-pay options for affordable access to medical weight loss care
This was followed by Victoza and later Saxenda, which marked an important shift, extending GLP-1 therapy from type 2 diabetes into obesity treatment
Avoid excessive intake
Safety Considerations and Provider Decision Framework Injectable semaglutide has established adverse event profiles: nausea (25-60%), vomiting, diarrhea, and rare reports of pancreatitis or thyroid concerns
US$ 23.32
US$ 24.12
US$ 27.96
US$ 23.55
US$ 28.55
US$ 26.04
US$ 24.93
US$ 22.50
